238 related articles for article (PubMed ID: 2825911)
21. CRF alters the infundibular LHRH secretory system from the medial preoptic area of female rats: possible involvement of opioid receptors.
Rivest S; Plotsky PM; Rivier C
Neuroendocrinology; 1993; 57(2):236-46. PubMed ID: 8389996
[TBL] [Abstract][Full Text] [Related]
22. ACTH releasing activity of KP-102 (GHRP-2) in rats is mediated mainly by release of CRF.
Hirotani C; Oki Y; Ukai K; Okuno T; Kurasaki S; Ohyama T; Doi N; Sasaki K; Ase K
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):54-60. PubMed ID: 15645295
[TBL] [Abstract][Full Text] [Related]
23. Effects of selective opioid-receptor blockade on the hypothalamo-pituitary-adrenocortical responses to surgical trauma in the rat.
Cover PO; Buckingham JC
J Endocrinol; 1989 May; 121(2):213-20. PubMed ID: 2547002
[TBL] [Abstract][Full Text] [Related]
24. Presynaptic opioid kappa-receptor and regulation of the release of Met-enkephalin in the rat brainstem.
Ueda H; Fukushima N; Ge M; Takagi H; Satoh M
Neurosci Lett; 1987 Oct; 81(3):309-13. PubMed ID: 2829060
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular and respiratory effects of mu-, delta- and kappa-opiate agonists microinjected into the anterior hypothalamic brain area of awake rats.
Pfeiffer A; Feuerstein G; Kopin IJ; Faden AI
J Pharmacol Exp Ther; 1983 Jun; 225(3):735-41. PubMed ID: 6306217
[TBL] [Abstract][Full Text] [Related]
26. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats.
Di Chiara G; Imperato A
J Pharmacol Exp Ther; 1988 Mar; 244(3):1067-80. PubMed ID: 2855239
[TBL] [Abstract][Full Text] [Related]
27. Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine.
Buckingham JC; Cooper TA
Neuroendocrinology; 1984 May; 38(5):411-7. PubMed ID: 6328347
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological characterization of opioid receptors influencing the secretion of corticotrophin releasing factor in the rat.
Buckingham JC; Cooper TA
Neuroendocrinology; 1986; 44(1):36-40. PubMed ID: 3024056
[TBL] [Abstract][Full Text] [Related]
29. Effects of intravenous and intraventricular injection of antisera directed against corticotropin-releasing factor on the secretion of anterior pituitary hormones.
Ono N; Samson WK; McDonald JK; Lumpkin MD; Bedran de Castro JC; McCann SM
Proc Natl Acad Sci U S A; 1985 Nov; 82(22):7787-90. PubMed ID: 2999777
[TBL] [Abstract][Full Text] [Related]
30. Kappa-receptor antagonist reverse 'non-opioid' stress-induced analgesia.
Panerai AE; Martini A; Sacerdote P; Mantegazza P
Brain Res; 1984 Jun; 304(1):153-6. PubMed ID: 6331578
[TBL] [Abstract][Full Text] [Related]
31. Effects of the opiate antagonists diprenorphine and naloxone and of selected opiate agonists on feeding behavior in guinea pigs.
Billington CJ; Herman BH; Bartness TJ; Levine AS; Morley JE
Life Sci; 1990; 46(2):147-54. PubMed ID: 2153888
[TBL] [Abstract][Full Text] [Related]
32. Corticotropin-releasing factor but not urocortin is involved in adrenalectomy-induced adrenocorticotropin release.
Masuzawa M; Oki Y; Ozawa M; Watanabe F; Yoshimi T
J Neuroendocrinol; 1999 Jan; 11(1):71-4. PubMed ID: 9918231
[TBL] [Abstract][Full Text] [Related]
33. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
[TBL] [Abstract][Full Text] [Related]
34. Interaction of corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo.
Rivier C; Vale W
Endocrinology; 1983 Sep; 113(3):939-42. PubMed ID: 6307672
[TBL] [Abstract][Full Text] [Related]
35. Effect of 41-CRF antiserum on the secretion of ACTH, B-endorphin and alpha-MSH in the rat.
Conte-Devolx B; Rey M; Boudouresque F; Giraud P; Castanas E; Millet Y; Codaccioni JL; Oliver C
Peptides; 1983; 4(3):301-4. PubMed ID: 6314292
[TBL] [Abstract][Full Text] [Related]
36. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.
Lu L; Liu D; Ceng X; Ma L
Eur J Neurosci; 2000 Dec; 12(12):4398-404. PubMed ID: 11122350
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effect of a new opioid agonist on reproductive endocrine activity in rats of both sexes.
Markó M; Römer D
Life Sci; 1983 Jul; 33(3):233-40. PubMed ID: 6865656
[TBL] [Abstract][Full Text] [Related]
38. Opiate receptor subtypes in the regulation of thyrotropin and prolactin secretion in the rat.
Rauhala P; Tuominen RK; Männistö PT
Horm Res; 1988; 29(5-6):218-22. PubMed ID: 2851523
[TBL] [Abstract][Full Text] [Related]
39. Bremazocine differentially antagonizes responses to selective mu and delta opioid receptor agonists in rat hippocampus.
Dunwiddie TV; Johnson KJ; Proctor WR
Br J Pharmacol; 1987 Jul; 91(3):523-30. PubMed ID: 3038241
[TBL] [Abstract][Full Text] [Related]
40. ACTH-(1-24) and alpha-MSH antagonize feeding behavior stimulated by kappa opiate agonists.
Poggioli R; Vergoni AV; Bertolini A
Peptides; 1986; 7(5):843-8. PubMed ID: 3025825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
